Drug Report

In a blind race to cure HIV, can Gene therapy be a deal-breaker?

Jan 20, 2020

HIV infection has become a global health burden, has claimed over 32 million lives so far since the very first case of AIDS was reported in 1981. According to a report put ...

Malignant Pleural Mesothelioma Upcoming Therapies

Jan 15, 2020

Malignant pleural mesothelioma treatment market includes several immunotherapy agents, in the pipeline including Keytruda, Opdivo and Yervoy, which have shown promising ant...

Malignant pleural mesothelioma market: Elusive treatment approaches and Poor diagnosis

Jan 13, 2020

Malignant pleural mesothelioma (MPM) is a malignancy of pleural layers within the lung cavity and inner sides of the ribs. Year of research has revealed asbestos expo...

Anaphylaxis: A Rare Disease

Jan 10, 2020

Anaphylaxis is a rare disease which can even result in life-threatening situations. Mostly the allergic reaction is due to food, insect stings, medications and latex. ...

Egg Allergy Market: Second most common food allergy but no approved therapy

Jan 6, 2020

Hen’s egg allergy is the second most common type of allergy after cow’s milk. In infants and young children, Egg poses as one of the most vital allergens degrading the ...

Chronic Hand Eczema Market Analysis and Forecast

Eczema is an umbrella term comprising skin disorders characterised by dry, discoloured, itchy and inflamed skin. Hand eczema (HE) are non-infectious, inflammatory cutaneous...

Angelman syndrome: A Rare Genetic Disorder

Jan 1, 2020

Angelman syndrome is a rare genetic disorder, which affects the nervous system. The people who are affected by the disease, show the characteristics like intellectual disab...

Atopic dermatitis market: Increasing prevalence and topical treatments

Dec 30, 2019

Atopic dermatitis, also known as atopic eczema, is a condition that results in itchy, scaly and red skin. It is an inflammatory skin disease which is a common recurrent for...

Wave Life Sciences stocks implode; Amarin’s VASCEPA approval; GSK seeks approval

Dec 17, 2019

Wave Life Sciences has recently announced the discontinuation of its drug suvodirsen, for the treatment of a rare Duchenne Muscular Dystrophy mutation. Duchenne Muscu...

Increasing cases of Mania and Bipolar disorder market

Dec 16, 2019

Bipolar Disorder is characterized by frequent-shifts in the mood and is a manic-depressive disorder hampering the routine life of an individual. According to the American P...

Fragile X Syndrome Market

Dec 13, 2019

AI-driven treatment approach and growing Fragile X Syndrome market size Healx Pharma has recently partnered with Boehringer Ingelheim to advance the treatment market and in...

Acquisition of ArQule; Synthorx; and Zentalis nabs a raise

Dec 10, 2019

Merck is set to complete the already planned purchase of the ArQule for USD 2.7 Billion. Under the terms of the agreement, Merck will pay USD 20 for each share in cash for ...

Are Rare Diseases truly Rare?

Dec 9, 2019

Rare diseases, as the name depicts, affect only a small number of people compared to the other disease. Worldwide, one out of 15 persons could be affected by a rare disease...

Cumberland’s methotrexate product gets approval in the US; Baker Brothers purchases stake in Kodiak’s KSI-301; Sanofi offloads Seprafilm unit to Baxter

Dec 3, 2019

Cumberland Pharmaceuticals has recently received approval from the US FDA for its RediTrex injection for the treatment of rheumatoid arthritis. Cumberland pharmaceuticals p...

Chronic Refractory Cough Market landscape: A new approach to treating cough

Dec 2, 2019

When cough seems everlasting, mortifying, and excruciating, it is high time to consult a physician as you might be stricken by chronic cough, which can be irritating and ma...